Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5852
Source ID: NCT02951260
Associated Drug: Metformin
Title: The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Metformin|OTHER: Placebo
Outcome Measures: Primary: Overall aerobic work performed during an exercise bout with self-selected intensity, Total oxygen consumption (L O2) during a 45 min ergometer cycling bout with self-selected intensity | Secondary: External work performed during an exercise bout with self-selected intensity, Total work produced (kJ) during a 45 min ergometer cycling bout with self-selected intensity|Rate of perceived exertion during an exercise bout with fixed intensity, Mean rate of perceived exertion (Borg scale) during a 45 min ergometer cycling bout with fixed intensity|blood lactate during an exercise bout with fixed intensity, Mean blood lactate (mmol/l) during a 45 min ergometer cycling bout with fixed intensity|Heartrate during an exercise bout with fixed intensity, Mean heart rate (bpm) during a 45 min ergometer cycling bout with fixed intensity|Respiratory exchange ratio during an exercise bout with fixed intensity, Mean VCO2/VO2 during a 45 min ergometer cycling bout with fixed intensity|Physical fitness (VO2max), maximal oxygen consumption (L/min) during a VO2 max test | Other: AMPK-activation in skeletal muscle during an exercise bout with fixed intensity, change in exercise induced AMPK-activation after compared to before a 45 min ergometer cycling bout with self-selected intensity|Oxidative phosphorylation in skeletal muscle fibers, Mitochondrial Complex I respiration in skeletal muscle tissue after 17 days of metformin/placebo treatment
Sponsor/Collaborators: Sponsor: Rigshospitalet, Denmark | Collaborators: University of Copenhagen
Gender: MALE
Age: ADULT
Phases:
Enrollment: 15
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Start Date: 2016-10
Completion Date: 2017-07
Results First Posted:
Last Update Posted: 2017-09-27
Locations: Center for aktiv sundhed, Copenhagen, Copenhagen N, 2200, Denmark
URL: https://clinicaltrials.gov/show/NCT02951260